Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Quebec Government to Reimburse Betaseron for Multiple Sclerosis MONTREAL, Dec. 9, 1996-- On December 8, 1996, Quebec's Health Minister, Dr. Rochon announced that Betaseron(R) (interferon beta-1b) - a breakthrough drug proven to reduce the frequency and severity of exacerbations for MS patients - will be reimbursed in Quebec. The Minister's approval of the MS medication was based on the recommendation of the "Conseil Consultatif de la Pharmacologie" (CCP), an expert body which advises the Minister on whether to list medications on the provincial insurance formulary based on their therapeutic value. QUEBEC JOINS INDUSTRIALISED COUNTRIES, AND ONTARIO By reimbursing this breakthrough drug, Quebec has joined France, Germany, Italy, Sweden, Denmark, Ireland, Austria, the M and the United States, all of which provide coverage for Betaseron. Ontario is the only other province which currently reimburses Betaseron under the Trillium Drug Program, although other Canadian provinces are considering reimbursement of Betaseron through their provincial insurance plans. "We were confident from the beginning because the scientific evidence is strong. Quebec, like other provinces, was provided with all of the information and criteria required to implement a program which will ensure proper patient access to Betaseron for patients who can benefit from it." Said Dr. Jean Francois Grenier, V.P. Scientific Affairs for Berlex Canada Inc. IMPROVES QUALITY OF LIFE "Its very important for Quebecers who suffer from MS and the families and friends who care for them. This means that many patients with relapsing emitting MS will have access to this unique treatment which can improve their quality of life. We hope that other Canadian provinces will follow shortly, providing a new lease on life for MS suffers across Canada." Berlex continues to do MS research and is committed to finding improved treatments for this disease. E-mail this page to a friend or colleague! To print, use this version